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Background: Several in-house PCR-based assays have been described for the detection of bac-
terial meningitis caused by Neisseria meningitidis,  Streptococcus pneumoniae,  and Haemophilus
inﬂuenzae  from clinical samples. PCR-based methods targeting different bacterial genes are
frequently used by different laboratories worldwide, but no standard method has ever been
established. The aim of our study was to compare different in-house and a commercial PCR-
based tests for the detection of bacterial pathogens causing meningitis and invasive disease
in  humans.
Methods: A total of 110 isolates and 134 clinical samples (99 cerebrospinal ﬂuid and 35
blood  samples) collected from suspected cases of invasive disease were analyzed. Speciﬁc
sets of primers frequently used for PCR-diagnosis of the three pathogens were used and
compared with the results achieved using the multiplex approach described here. Several
different gene targets were used for each microorganism, namely ctrA, crgA and nspA for N.
meningitidis,  ply for S. pneumoniae,  P6 and bexA for H. inﬂuenzae.
Results: All used methods were fast, speciﬁc and sensitive, while some of the targets used for
the in-house PCR assay detected lower concentrations of genomic DNA than the commercial
method. An additional PCR reaction is described for the differentiation of capsulated and
non-capsulated H. inﬂuenzae strains, the while commercial method only detects capsulated
strains.
Conclusions: The in-house PCR methods here compared showed to be rapid, sensitive, highly
speciﬁc, and cheaper than commercial methods. The in-house PCR methods could be easily
adopted by public laboratories of developing countries for diagnostic purposes. The bestd usiresults were achieveto  detect the lowest DNA 
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Neisseria subﬂava (ATCC 11076), Moraxella catarrhalis (ATCC
25238), Streptococcus agalactiae (ATCC 13813), Streptococcus pyo-336  b r a z j i n f e c t d 
Introduction
Infections caused by Neisseria meningitidis (Nm), Streptococcus
pneumoniae (Sp) and Haemophilus inﬂuenzae (Hi) are responsi-
ble for high morbidity and mortality rates among children
and adults in many  countries each year.1,2 Despite effective
antimicrobial and supportive therapy, mortality rates among
children remain high, with signiﬁcant long-term sequelae in
survivors. Although adequate treatment requires rapid detec-
tion and identiﬁcation of the bacteria, traditional laboratory
diagnostic methods such as culture for the identiﬁcation
of bacterial meningitis pathogens may take 36 h or more.
Because of the similarity of clinical symptoms among inva-
sive infections caused by Nm,  Sp and Hi, physicians must
frequently request laboratories to test the clinical sample for
these three microorganisms to determine the causative bacte-
ria and decide on the management of the case. Rapid diagnosis
of the etiological agent is also important for health surveil-
lance, in cases of invasive disease, to avoid transmission to
close contacts.1–3
To address this problem, nonculture methods like PCR
have become available during the last two decades, provid-
ing early and accurate diagnosis of bacterial meningitis.1,4–10
Because of its rapid, sensitive and speciﬁc results, PCR
is an important tool to improve the diagnostic of such
microorganisms. An additional advantage of PCR over con-
ventional laboratory methods is the possibility to detect
genomic DNA from clinical samples without the need of
previous culture. Recently, the use of a quantitative PCR
method called Real Time-PCR, have improved the diagnosis
of infectious agents based on molecular methods.11–17 How-
ever, the higher cost of reagents and equipment could be
a possible drawback to the implementation of this method
in public laboratories of developing countries. The use of
a basic PCR method, can be still more  appropriate for
diagnostic purposes in low-budget laboratories. A number
of different target genes have been used in several PCR-
based assays to speciﬁcally detect the genomic DNA of
these agents. For N. meningitidis nspA, ctrA and crgA, for H.
inﬂuenzae bexA and P6, and for S. pneumoniae ply and lytA
genes have been used as targets.4–10,18,19 In order to deter-
mine the best combination of primers, we  have developed
a simple multiplex PCR for the simultaneous detection of
the three main agents of meningitis worldwide, Nm,  Sp,
and Hi. The multiplex PCR method here described allows
the detection of the three microorganisms in a single-tube
reaction, saving time and reagents. Target species speciﬁc
genes used for Nm,  Hi, and Sp detection were nspA, P6,
and ply respectively. Primers amplifying higher length frag-
ments were chosen for identiﬁcation because the visualization
of bands below 200 bp through electrophoresis may not be
clear depending of the agarose gel type and concentration
used. Furthermore, we  have compared the speciﬁcity and
sensitivity of our method to other in-house and commercial
PCR-based methods previously described for simultaneous
or single detection of Nm,  Hi, and Sp from clinical
samples.4,5,7–10,18,19 1 6;2  0(4):335–341
Materials  and  methods
Bacterial  isolates,  clinical  samples,  and  culture  conditions
We have analyzed a total of 110 strains isolated from clinical
samples (N. meningitidis n = 31, H. inﬂuenzae n = 29, S. pneumo-
niae n = 50) which are part of the Bacterial Culture Collection
of the INCQS/FIOCRUZ institute. The strains were isolated dur-
ing the last ﬁve years, from clinical samples of cerebrospinal
ﬂuid (CSF) and blood. These samples have been collected from
culture-conﬁrmed cases of patients with suspected meningi-
tis in Brazilian public hospitals. The isolates were recovered
from clinical samples after inoculation in chocolate agar
(blood agar base with 5% sterile defribinated rabbit blood at
56 ◦C) and incubated at 37 ◦C in a 5% CO2 environment. The
isolated strains were identiﬁed as Nm, Hi, or Sp by colony
morphology, latex agglutination of speciﬁc antisera (Slidex
Meningitis – Biomerieux), Gram staining and optochin suscep-
tibility, the latter only for Sp determination. Each species was
conﬁrmed by speciﬁc PCR tests8,18,19 freeze-dried and incor-
porated into the culture collection.
We have also analyzed 134 clinical samples (99 CSF and
35 blood) collected from suspected cases of invasive disease.
Thirty four (25.3%) of these samples were considered posi-
tive for one of the three pathogens targeted in this study by
conventional laboratory tests (culture, microscopy, and latex
agglutination) and 100 samples were considered negative after
conventional laboratory tests, but collected from patients with
suspected symptoms or epidemiological link to invasive dis-
ease caused by one of the three agents here described. The
study has been approved by the local research ethics commit-
tee.
Twenty nine reference strains were used as positive con-
trols as follows: N. meningitidis serogroup A (ATCC 13077), N.
meningitidis serogroup B (ATCC 13090), N. meningitidis serogroup
C (ATCC 13102), N. meningitidis serogroup W135 (ATCC 35559),
H. inﬂuenzae (ATCC 33391), H. inﬂuenzae aegyptius (ATCC 11116),
H. inﬂuenzae NT (ATCC 49247), H. inﬂuenzae serotype a (ATCC
9006), H. inﬂuenzae serotype b (ATCC 33533) H. inﬂuenzae
serotype c (ATCC 9007), H. inﬂuenzae serotype d (ATCC 9008),
H. inﬂuenzae serotype e (ATCC 8142), H. inﬂuenzae serotype
f (ATCC 9833), S. pneumoniae (ATCC 33400), S. pneumoniae
serotype 14 (ATCC 6314), S. pneumoniae serotype 3 (ATCC
6303), S. pneumoniae serotype 33 (ATCC 8333), S. pneumoniae
serotype 41 (ATCC 10341), S. pneumoniae serotype 51 (ATCC
10351), S. pneumoniae serotype 19F (ATCC 49619), S. pneumo-
niae serotype 61 (ATCC 10361), S. pneumoniae serotype 19A
(ATCC 700673), S. pneumoniae serotype 14 (ATCC 700672), S.
pneumoniae serotype 9V (ATCC 700671), S. pneumoniae serotype
6B (ATCC 700670), S. pneumoniae serotype 4 (ATCC BAA-334),
S. pneumoniae serotype 6A (ATCC BAA-659), S. pneumoniae
serotype 5 (ATCC BAA-341). Other 9 reference strains were
also used as negative controls as they can also cause bacte-
rial meningitis in humans: Neisseria lactamica (ATCC 23970),genes (ATCC 19615), Klebsiella pneumoniae (ATCC 13883), Listeria
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onocytogenes (ATCC 15313), Acinetobacter sp. (ATCC 14293),
scherichia coli (ATCC 11775).
xtraction  and  puriﬁcation  of  bacterial  DNA
enomic DNA extraction and puriﬁcation from isolated strains
nd negative clinical samples was carried out using the
Neasy Blood and Tissue extraction kit (Qiagen) according
o manufacturer instructions. Brieﬂy, 200 l of the clinical
ample were processed using the above mentioned extrac-
ion kit, which allows total puriﬁcation of bacterial genomic
NA free of contaminants and enzyme inhibitors. Extrac-
ion and puriﬁcation of DNA was achieved using different
ashing buffers and separation on Anion-Exchange Resin
olumns by binding of nucleic acids and further elution for
nal use. Puriﬁed DNA were kept at −20 ◦C for repeated exper-
ments.
rimer  design  and  PCR  conditions
peciﬁc sets of primers frequently used for PCR-diagnosis of
he three above-mentioned agents were used and compared
ith the results achieved using the multiplex approach here
escribed (Table 1). For the detection of Nm by PCR, target-
enes ctrA, crgA and nspA were used, for Sp detection two
ifferent regions of the target-gene ply were used. Primers
ly-894 and ply-974 were described by Corless et al.,11 target-
ng a speciﬁc region of the pneumococcus pneumolysin gene
ply) amplifying a 80 bp amplicon. A new pair of primers was
esigned to amplify a larger segment of the ply gene. We used
he S. pneumoniae pneumolysin gene GenBank access #M17717
equence as template for primers design. The region ampli-
ed was located between positions 555 and 1554 of the ply
ene M17717. For Hi detection, target genes P6 and bexA were
Table 1 – Primers sequences used in this study.
Microrganisms and primers 
Streptococcus pneumoniae
ply-894: 5′-TGCAGAGCGTCCTTTGGTCTAT-3′
ply-974: 5′-CTCTTACTCGTGGTTTCCAACTTGA-3′
Multiplex
ply-1:  5′-GACCCCAGCAATTCAATTCAAGTGT-3′
ply-2:  5′-TACGCACTAGTGGCAAATCG-3′
Neisseria meningitidis
ctrA-617:  5′-GCTGCGGTAGGTGGTTCAA-3′
ctrA-727:  5′-TTGTCGCGGATTTCGAACTA-3′
crgA-F: 5′-GCTGGCGCCGCTGGCAACAAAATTC-3′
crgA-R: 5′-CTTCTGCAGATTGCGGCGTGCCGT-3′
Multiplex
nspA1: 5′-AGCACTTGCCACACTGATTG-3′
nspA2: 5′-GGAACGGACGTTTTTGACAG-3′
Haemophilus inﬂuenzae
Multiplex
HiP6-F 5′-ACTTTTGGCGGTTACTCTGT-3′
HiP6-R 5′-TGTGCCTAATTTACCAGCAT-3′
bexA-142:  5′-GGCGAAATGGTGCTGGTAA-3′
bexA-241:  5′-GGCCAAGAGATACTCATAGAACGTT-3′6;2 0(4):335–341 337
used (Table 1). PCR was carried out using the PCR-MasterMix
(Promega) DNA ampliﬁcation kit according to manufacturer
speciﬁcations with an equimolar mixture of the four primer
pairs at 50 pmol/l  each for the multiplex approach. PCR was
run on an Eppendorf Mastercycler EP thermocycler with 35
cycles of 95 ◦C for 30 s, 50 ◦C for 1 min, 72 ◦C for 1 min  and 30 s
and a ﬁnal extension of 72 ◦C for 10 min. A 10 l sample of
the completed reaction mixture was run in a 1% agarose gel
stained with ethidium bromide. Ampliﬁed products were visu-
alized and photographed under UV light. We  have also used a
commercial kit for the detection of the three agents targeted
in this study, named SPEED-OLIGO BACTERIAL MENINGITIS
from Vircell which is a PCR-based method coupled to a dip-
stick device that enables speciﬁc detection of H. inﬂuenzae,
N. meningitides, and S. pneumoniae in cerebrospinal ﬂuid sam-
ples. The reactions were carried out according to the producer
instructions.
Puriﬁed DNA of three reference strains: Nm ATCC 13090,
Hi ATCC 33533, 49247, and Sp ATCC 33400 were diluted to an
undetectable level for sensitivity determination. Tenfold serial
dilutions ranging from 10 g to 10 fg DNA per l were used in
single and multiplex PCR giving a range of different sensitivity
according to the speciﬁc set of primers used (Table 2). Consid-
ering a genome size of roughly 2 Mb for Nm,  Sp, and Hi and
since 1 kb of ds DNA has a molecular mass of 660 kDa, 10 fg of
DNA represent ﬁve genomes.
The differentiation of capsulated and non-capsulated H.
inﬂuenzae strains was carried out by the inclusion of bexA
and P6 primer sets in a second multiplex assay. The pres-
ence of two bands at 343 bp and 273 bp indicated a capsulated
Hi strain. With this result an additional PCR is required for
serotype determination. The presence of a single band at
273 bp indicates a non-capsulated Hi strain and no further
serotype determination was necessary.
Amplicon length (bp) Reference
80 Corless et al. (2001)11
1000 This study
111 Corless et al. (2001)11
230 Taha (2000)5
481 de Filippis et al. (2005)8
273 van Ketel et al. (1990)18
343 Falla et al. (1994)19
338  b r a z j i n f e c t d i s . 2 0 1 6;2  0(4):335–341
Table 2 – Sensitivity of in-house-PCR and commercial PCR-based detection kit.
Micro-organism Gene target DNA detection limitsa
In-house PCR
Neisseria meningitidis
ATCC 13090
nspA  (de Filippis et al., 20058) 36.8 fg/L(U/M)
Neisseria meningitidis
ATCC 13090
ctrA  (Corless et al., 200111) 52 pg/L(U)
Neisseria meningitidis
ATCC 13090
crgA  (Taha, 20005) 52 pg/L(U)
Streptococcus pneunoniae
ATCC 33400
ply  (Corless et al., 200111) 21.4 pg/L(U)
Streptococcus pneunoniae
ATCC 33400
ply  (this study) 80  fg/L(U/M)
H. inﬂuenzae
ATCC 49247
P6  (van Ketel et al., 199018) 100 fg/L(U/M)
Speed-oligo/MEDIVAX
Neisseria meningitidis
ATCC 13090
ctrA  520 fg/L
Streptococcus pneunoniae
ATCC 33400
lytA 214  pg/L
Haemophilus inﬂuenzae
ATCC 33533
bexA  206 pg/L
previously scored as positive and for additional 12 samples
which were scored as negative after conventional laboratory
tests giving a total of 46 (34.3%) PCR positive samples (Table 3).
Fig. 1 – Agarose gel of a multiplex PCR showing the
detection of the three pathogens from three differenta U, uniplex-PCR; M, multiplex-PCR.
Results
Novel  multiplex  PCR
The multiplex PCR approach here described is capable to
simultaneously detect genomic DNA of the three agents above
described. The three primer pairs used for speciﬁcally indi-
cate the etiological agent are nspA (Nm), P6 (Hi), and ply (Sp)
giving bands with different sizes: 481 bp, 273 bp, and 1000 bp,
respectively (Fig. 1). When a positive result is achieved for
Hi, an additional PCR is carried out in order to determine if
the strain is capsulated. For this second PCR round, speciﬁc
primers for targeting the bexA gene are used. Ampliﬁcation
of a 343 bp DNA fragment, conﬁrms the presence of a capsu-
lated strain which should be further analyzed to determine
the serotype. No ampliﬁcation after the second PCR round,
indicates a non-typeable Hi (HiNT) (Fig. 2).
Speciﬁcity
The speciﬁcity of the assay was assessed by testing a panel
of non-Nm, Sp, or Hi strains, which included DNAs from nine
pathogenic bacteria which may cause invasive disease with
symptoms similar to those caused by the three target orga-
nisms. No ampliﬁcation was observed after PCR with any of
the microorganisms tested.
Sensitivity
Uniplex and multiplex PCR using the primer sets and the com-
mercial kit here described, showed positive ampliﬁcation for
at least one of the three targets with all the 110 clinical isolates
of Nm,  Sp, and Hi. For CSF and blood samples, the sensitivity
of PCR for detecting bacterial meningitis or septicemia wasable  to detect bacterial genomic DNA of all the 34 samplessamples. Lane 1: 100 bp DNA ladder; lane 2: Neisseria
meningitidis (nspA gene with 481 bp); lane 3: Haemophilus
inﬂuenzae (P6 gene with 273 bp); lane 4: Streptococcus
pneumoniae (ply gene with 1000 bp); lane 5: negative control.
b r a z j i n f e c t d i s . 2 0 1 6;2 0(4):335–341 339
Table 3 – Sensitivity and speciﬁcity of primer sets.
PCR primers Positive samples by conventional tests/by PCR 
Nm  Sp Hi    PPV/NPV (%)
nspA - 1/2 15/20 a --- --- 100/100
Neisseria ctrA - 617/727 15/20 --- --- 100/100
meningitidis crgA - F/R 15/20 --- --- 100/100
Streptococcus ply - 894/974 --- 12/16 --- 100/100
pneumoniae ply - 1/2 --- 12/16 --- 100/100
Haemophilus    bexA- 142/241 --- --- 7/10 100/100
influenzae P6- F/R --- --- 7/10 100/100
Speed- oligo
Nm 15/20 --- --- 100/100
Sp --- 12/16 --- 100/100
Hi --- --- 7/10 100/100
HiNT --- --- 7/10 100/100
PPV, Positive Predictive Value; NPV, Negative Predictive Value; Nm, Neisseria meningitides; Sp, Streptococcus pneumoniae; Hi,Haemophilus influenza.
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((a) total number of clinical samples tested for each agent: Nm n=20, Sp n=16, Hi n=1
omparison  of  detection  limits  of  single,  multiplex,  and
ommercial  PCR  methodse  have compared different primer sets for the detection of
he three microorganisms on single and multiplexed reac-
ions. PCR was carried out as a single or multiplexed reaction
ig. 2 – Agarose gel showing the differentiation of
apsulated and non-capsulated Haemophilus inﬂuenzae
trains. Lane 1: 100 bp DNA ladder; lane 2: capsulated H.
nﬂuenzae (bexA and P6 genes with 343 bp and 273 bp
espectively); lane 3: non-capsulated H. inﬂuenzae (HiNT),
bexA gene with 343 bp); lane 4 negative control.performed with the sets of primers described in Table 1. For
the commercial kit, the reactions were performed only as a
single test (uniplex) for each pathogen as recommended by
the producer. As it is shown in Table 2, conventional PCR test
using primers targeting genes nspA,8 ply (this study) and P618
were able to detect the lowest DNA dilutions of each speciﬁc
target (36.8 fg/L, 80 fg/L and 100 fg/L, respectively) both in
the uniplex or multiplex approach. The commercial test SPEED
OLIGO targeting genes ctrA, lytA, and bexA showed to be less
sensitive than the conventional PCR test (Table 2).
Discussion
Conventional PCR is still widely used as a straightforward lab-
oratory test to detect speciﬁc DNA of different pathogens such
as virus, bacteria, and protozoa from human or animal clini-
cal samples. Several conventional PCR-based tests have been
described for single or simultaneous detection of the most
frequent bacterial agents causing invasive disease and menin-
gitis in humans, namely N. meningitidis, S. pneumoniae, and
H. inﬂuenzae.4–10 Gene targets vary according to the micro-
bial agent showing similar sensitivity and speciﬁcity. There
are few commercial tests based on molecular strategies avail-
able for the detection of these pathogens. One  of these tests
is the Oligo Speed here compared to conventional PCR-based
methods targeting different genes for each microbial agent. A
great concern on this matter lately raised is the intra-strain
gene polymorphism found within meningococcal strains as
described on a study.20 False-negative results by real-time PCR
were described for the ctrA gene used as a diagnostic target.
Our results show that the combination of speciﬁc primers tar-
geting genes nspA, ply,  and P6 on a multiplex approach was
able to detect at least 10 gene copies of each bacterial agent.
Two variants of H. inﬂuenzae causing either invasive or non-
invasive disease have been described. The most common is
the capsulated Hi variant whose capsule is classiﬁed accord-
ing to its polysaccharide structure into six different serotypes
(a, b, c, d, e and f) which can be detected using PCR.19 However,
i s . 2 0
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this approach fails to identify non-capsulated strains since it
is based on the ampliﬁcation of a genetic capsule structure.
The most common virulence factor of Hi strains is the capsule
which helps the bacteria to evade the host immune system.
Nevertheless, an increasing number of non-typeable strains
has been reported causing different forms of disease21–23 and
the occurrence of these strains associated to invasive and
non-invasive disease has been reported as a concern for new
vaccines design.24,25 van Ketel et al.18 described an outer
membrane protein (P6) which is exclusively found in all H.
inﬂuenzae strains and it is not related to the presence of the
capsule, being suitable to discriminate between capsulated
and non-capsulated strains through a simple PCR. Failure to
amplify the bexA gene and ampliﬁcation of the P6 gene indi-
cates a non-capsulated Hi strain. The single use of primers for
the detection of the P6 gene would be sufﬁcient for the detec-
tion of Hi strains, but this approach alone would not indicate
if the strain is non-capsulated, an important information for
epidemiologic surveillance after the introduction of the con-
jugated Hib vaccine. An additional PCR reaction is required
targeting the bexA gene to determine if the strain is capsulated
and in this case a serotype-speciﬁc PCR can be performed for
serotype determination as described by Falla et al.19 The inclu-
sion of an additional PCR with primers targeting the Hi capsu-
lar gene bexA is important, since it can differentiate capsulated
to non-capsulated Hi strains (NTHi) which has been consid-
ered as a potential emerging pathogen in countries where the
conjugated vaccine against Hib has been introduced.21,24–29
An additional advantage of the multiplex system here
described is that there is no possibility of misinterpretation
of the speciﬁc bands with primer excess, which is frequently
found below 100 bp, since the length of the shortest band is
273 bp for the bexA gene fragment and other bands are located
at 343 bp (P6), 481 bp (nspA) and 1000 bp (ply). Other PCR-
based methods use real-time PCR primers which may generate
short-length amplicons with difﬁcult preview by agarose gel
electrophoresis.7,10
Sensitivity was assessed using clinical samples (CSF and
whole blood) from culture-conﬁrmed cases for one of the
three organisms. Sensitivity for Nm,  Sp, and Hi was 100%
since all positive cases conﬁrmed by culture gave positive PCR
result. Furthermore, 12 samples associated to suspected cases
were also scored positive by the multiplex PCR approach here
described. It is likely that these samples were considered neg-
ative due to previous antibiotic treatment. The use of the novel
multiplex PCR gave a total of 46 (34.3%) PCR positive samples
(Table 3). These results showed how sensitive is the test when
other phenotypic or epidemiological results indicate that the
agent causing disease could be one of those three bacterial
pathogens. Problems related to culture and isolation of these
bacteria are frequently reported by several laboratories, where
a speciﬁc and sensitive molecular test is crucial for the rapid
and accurate identiﬁcation of the disease causing agent.
Real-time PCR has been pointed as advantageous over
conventional PCR due to its higher sensitivity and faster
resolution since the result can be monitored during the run.
However, real-time PCR does not appear to offer advantages
when used by public laboratories for broad-range PCR testing
a large number of samples. In fact, there may be disadvan-
tages, such as need of trained technical staff, controlled 1 6;2  0(4):335–341
environment for assay setups, and higher cost of equipment
and reagents. For public or private laboratories that still use
conventional PCR to detect such pathogens, the choice for
the best multiplex system is crucial to achieve accurate and
reliable results. In the present study, we were able to compare
several different primers combinations and gene targets
recently described by different authors, with a commercial
PCR-based test for the detection of the three agents. Our
data show that the most sensitive and reliable combination
of primers for a multiplex approach include the following
targets: nspA gene for N. meningitidis generating a 481 bp
amplicon,8 ply gene for S. pneumoniae generating a 1000 bp
amplicon (sequence described in this study), and P6 gene
for H. inﬂuenzae generating a 273 bp amplicon.18 For the dis-
crimination between capsulated and non-capsulated strains
of H. inﬂuenzae,  an additional PCR is required, targeting the
bexA gene generating a 343 bp amplicon,19 when a positive
ampliﬁcation of the P6 gene is observed.
We believe that the standardization of conventional PCR-
based tests for the detection of the invasive bacterial agents
here described could improve, interoperability, reproducibility,
and quality among different worldwide laboratories involved
in routine clinical analysis.
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